Catalent

Arcturus Therapeutics, Catalent Announce Partnership To Manufacture Covid-19 Vaccine
Arcturus Therapeutics, Catalent Announce Partnership To Manufacture Covid-19 Vaccine
Reuters
Arcturus Therapeutics
Catalent
vaccines
COVID-19
Flag link:
Catalent and Johnson & Johnson Sign Coronavirus Vaccine Manufacturing Deal
Catalent and Johnson & Johnson Sign Coronavirus Vaccine Manufacturing Deal
Motley Fool
JNJ
Catalent
COVID-19
vaccines
drug manufacturing
Flag link:
Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round
Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round
Fierce Pharma
Perrigo
Catalent
Teva Pharmaceutical
ProAir HFA
asthma
COPD
generics
Flag link:
Catalent laying out $315M to snatch another gene therapy CDMO
Catalent laying out $315M to snatch another gene therapy CDMO
Fierce Pharma
Catalent
gene therapy
Paragon Services
CDMOs
Flag link:
Insurers Take Aim at Big Pharma. This Small-Cap Stock Stands to Win
Insurers Take Aim at Big Pharma. This Small-Cap Stock Stands to Win
Motley Fool
insurers
generics
Catalent
Flag link:
Drug/Biotech Stocks Nov 5 Earnings Roster: AGN, REGN & More
Drug/Biotech Stocks Nov 5 Earnings Roster: AGN, REGN & More
Yahoo/Zacks.com
Allergan
Regeneron
Mylan
Catalent
Jazz Pharmaceuticals
Flag link:
This Company Is Looking to Win Big in Gene Therapy
This Company Is Looking to Win Big in Gene Therapy
Motley Fool
Catalent
gene therapy
drug manufacturing
Flag link:
Catalent picks up Novavax facilities, 100 employees
Catalent picks up Novavax facilities, 100 employees
Biopharma Dive
Paragon Gene Therapy
Catalent
CMO
Novavax
Flag link:
'It's a growth play': Catalent acquires Bristol-Myers' European launch pad, expanding global CDMO ops
'It's a growth play': Catalent acquires Bristol-Myers' European launch pad, expanding global CDMO ops
Endpoints
Catalent
Europe
Bristol-Myers Squibb
Italy
gene therapy
CDMOs
Flag link:
Scratch that: Biogen's board expansion hits snag as Catalent CEO John Chiminski drops out
Scratch that: Biogen's board expansion hits snag as Catalent CEO John Chiminski drops out
Fierce Pharma
Biogen
John Chiminski
Catalent
Flag link:
Another Week, Another Gene Therapy Buyout: Catalent Pays $1.2B for Paragon
Another Week, Another Gene Therapy Buyout: Catalent Pays $1.2B for Paragon
Xconomy
gene therapy
M&A
Catalent
Paragon Bioservices
Flag link:
Catalent inks $133M deal to buy Juniper Pharmaceuticals, adding UK development services
Catalent inks $133M deal to buy Juniper Pharmaceuticals, adding UK development services
Endpoints
Catalent
Juniper Pharmaceuticals
UK
M&A
drug development
Flag link:
With CRO consolidation in full swing, Catalent inks a $950M deal to acquire Cook Pharmica
With CRO consolidation in full swing, Catalent inks a $950M deal to acquire Cook Pharmica
Endpoints
CROs
Catalent
M&A
Cook Pharmica
R&D
Flag link:
Catalent Rises on Report Lonza Group Offered to Buy It
Catalent Rises on Report Lonza Group Offered to Buy It
Bloomberg
Catalent
Lonza
drug delivery
M&A
Flag link:
China Biotech In Review: Simcere Receives $503 Million Privatization Offer
China Biotech In Review: Simcere Receives $503 Million Privatization Offer
Seeking Alpha
Simcere
Shanghai Pharmaceutical
Catalent
ShangPharma
Pathwork Diagnostics
Sinovac Biotech
BravoBio
Flag link:
Catalent pairs with BASF on biovailability challenges
Catalent pairs with BASF on biovailability challenges
NJ Biz, NJ
Catalent
BASF
Flag link: